AB1460 prohibits prescription drug manufacturers from engaging in discriminatory practices against qualifying nonhospital 340B community clinics.
AB1460 adds Section 127472 to the Health and Safety Code, prohibiting prescription drug manufacturers from engaging in discriminatory practices that would interfere with a qualifying nonhospital 340B community clinic’s purchase or delivery of a drug eligible for discounts under federal pricing requirements. The bill defines "discriminatory practices" and "qualifying nonhospital 340B community clinic" for these purposes.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.